Wedbush reiterates Tesla stock rating on chip factory plans By Investing.com

Wedbush maintained an Outperform and $600 price target on Tesla as Elon Musk announced two new Austin chip fabs (a Terafab) targeting ~1 terawatt annual capacity (~2x current U.S. production); Tesla shares trade at $383.98, down 15% YTD. Analysts are split: Stifel reiterated Buy citing strong Q4 2025 gross margin of 20.1% despite >$500M in tariffs, while GLJ Research stayed Sell over FSD recall risk; Barclays and Morgan Stanley kept Equalweight views and Wedbush flagged chip/memory supply as the biggest constraint. Regulatory risk escalated as NHTSA upgraded its FSD probe to a detailed engineering analysis covering ~3.2M vehicles; timeline and capex implications (potentially >$20B) remain uncertain.

Analysis

Tesla’s move toward in-house advanced-node chip capacity is a structural demand shock for the semiconductor ecosystem rather than a simple reshuffling of existing orders. If Tesla targets capacity on the order of “US-scale” production, expect incremental fab-equipment and materials spending measured in multiple tens of billions over 3–5 years, which disproportionately benefits ASML/LRCX/KLA and specialty chemical/substrate suppliers while crowding out available wafer slots for legacy customers.

Second-order competitive effects: OEM vertical integration raises counterparty concentration risk for leading foundries and memory vendors—their growth curves now need to incorporate the chance that a top OEM will internalize a material share of its logic/memory spend within a multi-year window. That makes TSMC and Micron more sensitive to idiosyncratic demand shocks and could compress realized pricing in the next 12–36 months if other OEMs follow suit or if Tesla leverages long-term offtake agreements.

Key catalysts and tail risks are timeline, yield, and regulation. Operationally, advanced-node fabs typically take 24–48 months from groundbreaking to production and another 12–36 months to reach competitive yields; a miss in either compresses Tesla’s margin optionality and forces higher near-term capex or partner deals. On the regulatory front, cross-domain consolidation (auto + launch + orbital datacenters) invites national-security review and export-control friction that can delay or effectively cap the project, creating sharp binary outcomes for related equities within 6–24 months.

Key Decisions for Investors

• Long semiconductor equipment exposure (LRCX, KLAC) — 6–18 month horizon. Buy LRCX shares or 12-month calls (~1–2% NAV). Rationale: fab buildout drives multi-year tool demand; target +30–50% upside if Tesla proceeds; downside ~20% if macro slows. Use 15–20% trailing stop or sell-to-close on 50% gain.
• Hedge/sell TSM (TSM) — 6–24 month horizon. Initiate a modest short-protection position: buy 12-month 25% OTM puts (size 2–3% NAV) financed by selling 3–6 month calls. Rationale: increased vertical integration and customer concentration risk compresses growth multiple; limited premium outlay (<3% notional) but asymmetric payoff if wafer demand shifts. Close/roll if TSM announces compensating large customer wins or capacity expansion within 9–12 months.
• Volatility-structured trade on TSLA to play timing mismatch — 12–36 month horizon. Buy longer-dated OTM calls (e.g., Jan 2028 $500s) while selling nearer-term calls (6–12 months) to finance cost, sizing at 2–4% NAV. Rationale: project value is multi-year and binary; this captures upside if Tesla successfully monetizes AI/robotaxi without taking large equity dilution, while near-term call sales capture premium given timeline uncertainty. Max loss = net premium paid; target asymmetric upside >3x premium.
• Pair idea: long specialty chem/substrate names (e.g., TOK/ENPH analogs in supply chain) / short foundry exposure — 12–36 month horizon. Size pair to be market-neutral at initiation (~1–2% NAV net). Rationale: fab builds lift equipment and materials faster than foundries’ revenue if OEMs internalize final assembly/packaging. Exit on confirmed multi-fab procurement announcements or if foundries announce large capacity expansions within 12 months.